KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$5.48
-0.09 (-1.62%)
Open$5.51
Previous Close$5.57
Day High$5.77
Day Low$5.40
52W High$10.99
52W Low$3.51
Volume—
Avg Volume2.94M
Market Cap104.01M
P/E Ratio—
EPS$-16.60
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+796.7% upside
Current
$5.48
$5.48
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 182.09M | 186.57M | 24.30M |
| Net Income | -244,386,059 | -225,355,997 | -4,467,152 |
| Profit Margin | -134.2% | -127.5% | -18.4% |
| EBITDA | -190,263,892 | -185,195,386 | -5,147,496 |
| Free Cash Flow | — | — | -3,231,735 |
| Rev Growth | -2.4% | -2.4% | +18.6% |
| Debt/Equity | 3.78 | 3.78 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |